Prab: CSV import

2025-03-17T13:18:39Z

CSV import

← Older revision		Revision as of 13:18, 17 March 2025
Line 21:		Line 21:
	{{pharma-stub}}		{{pharma-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T18:20:02Z

CSV import

← Older revision		Revision as of 18:20, 10 February 2025
Line 20:		Line 20:

	{{pharma-stub}}		{{pharma-stub}}
			{{No image}}

Prab: CSV import

2024-03-30T03:56:40Z

CSV import

New page

'''Glycoprotein Nmb''' ('''GPNMB''') is a type of [[glycoprotein]] that is encoded by the ''GPNMB'' gene in humans. This protein is also known by several other names, including osteoactivin and hematopoietic growth factor inducible neurokinin-1 type. GPNMB plays a significant role in various biological processes, including cell differentiation, [[immune response]], and the regulation of [[tumor]] growth and metastasis. Its expression has been observed in multiple tissue types and is notably upregulated in certain pathological conditions such as [[melanoma]], breast cancer, and [[glioblastoma]].

==Function==
GPNMB is involved in several critical cellular functions. It has been implicated in the regulation of [[cell growth]], [[cell differentiation]], and the [[immune system]]'s response to injury and infection. GPNMB can act as a signaling molecule, influencing the behavior of neighboring cells. In the context of cancer, GPNMB may contribute to tumor progression by promoting cell proliferation, migration, and invasion. Additionally, it has been associated with the suppression of the immune system's ability to target tumor cells, thereby facilitating tumor survival and growth.

==Clinical Significance==
The overexpression of GPNMB in various cancers has made it a target of interest for cancer therapy. Its role in promoting tumor growth and metastasis, along with its presence on the surface of tumor cells, makes it a potential target for [[immunotherapy]] and targeted drug delivery systems. Research is ongoing to develop therapies that can inhibit GPNMB's function or expression, with the aim of reducing tumor growth and spread.

In addition to its implications in cancer, GPNMB has been studied for its role in other diseases, such as [[osteoporosis]] and [[inflammatory diseases]]. Its involvement in cell differentiation and immune response suggests that it could be a target for therapeutic interventions in these conditions as well.

==Genetics==
The ''GPNMB'' gene is located on human chromosome 7. Variations in this gene have been studied in the context of their potential association with susceptibility to certain diseases, including cancer and inflammatory conditions. Understanding the genetic regulation of GPNMB expression is crucial for developing targeted therapies.

==Research Directions==
Current research on GPNMB is focused on elucidating its precise biological functions and its role in disease progression. Studies are also aimed at developing therapeutic agents that can target GPNMB, including monoclonal antibodies and small molecule inhibitors. The potential of GPNMB as a biomarker for certain cancers is another area of active investigation, which could lead to improved diagnostic and prognostic tools.

[[Category:Glycoproteins]]
[[Category:Human proteins]]
[[Category:Cancer research]]

{{pharma-stub}}

GPNMB - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import